![](/img/cover-not-exists.png)
624PDPreliminary results of a ph2a study to evaluate the clinical efficacy and safety of erdafitinib in Asian patients with biomarker-selected advanced cholangiocarcinoma (CCA)
Chen, Y-Y, Park, J O, Su, W-C, Oh, D-Y, Kim, K-P, Feng, Y-H, Shen, L, Liao, H, Nie, J, Qing, M, Li, J, De Porre, PVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy282.008
Date:
October, 2018
File:
PDF, 75 KB
2018